Non-safety recall of MedImmune's H1N1 vaccine over potency
This article was originally published in Scrip
Executive Summary
MedImmune (AstraZeneca) is recalling doses of its nasal spray H1N1 vaccine after routine tests showed a decline in potency, according to the US Centers for Disease Control and Prevention (CDC).